Objective: To evaluate clinical value of p161NK4a biomarker level, by doing p161NK4a immunocytochemistry staining, as a pre¬dictor of progressivity of precancerous cervical lesion. Method: Design of this research is case-control study which will be stratified. ~search was conducted in Cytology Laboratorium, Gynecology Specialistic Division, Department of Obstetrics and Gynecology, Dr. Cipto M…
Aim To identify the predictive factors and biomarkers in the progression of cervical precancer lesion or Cervical intraepithelial Neoplasia (CIN). Methods The study was conducted from August 2007 to September 2008. Design of the study was case-control with stratifications of test dose response. The cases were patients with CIN. Control patients were non CIN patients. Bivariate analysis followe…